flumazenil has been researched along with Dyslipidemia in 2 studies
Flumazenil: A potent benzodiazepine receptor antagonist. Since it reverses the sedative and other actions of benzodiazepines, it has been suggested as an antidote to benzodiazepine overdoses.
flumazenil : An organic heterotricyclic compound that is 5,6-dihydro-4H-imidazo[1,5-a][1,4]benzodiazepine which is substituted at positions 3, 5, 6, and 8 by ethoxycarbonyl, methyl, oxo, and fluoro groups, respectively. It is used as an antidote to benzodiazepine overdose.
Excerpt | Relevance | Reference |
---|---|---|
"Obesity-induced metabolic syndrome is a multiple risk factor for cardiovascular (CV) risk factors and type 2 diabetes, and ethnic minorities seem to have unfavourable medical risk factors in general more frequently than majority populations." | 1.40 | Prevalence of cardiovascular risk factors in relation to metabolic syndrome in the Roma population compared with the non-Roma population in the eastern part of Slovakia. ( Babcák, M; Babinská, I; Cecetková, B; Drazilová, S; Fedacko, J; Gecková, AM; Janicko, M; Jankajová, M; Jarcuska, P; Kalanin, P; Kmec, J; Mareková, M; Pazinka, P; Pella, D; Pella, J; Sabol, F; Siegfried, L; Veselíny, E, 2014) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fedacko, J | 1 |
Pella, D | 1 |
Jarcuska, P | 2 |
Siegfried, L | 1 |
Janicko, M | 1 |
Veselíny, E | 1 |
Pella, J | 1 |
Sabol, F | 1 |
Mareková, M | 1 |
Gecková, AM | 1 |
Pazinka, P | 1 |
Jankajová, M | 1 |
Kmec, J | 1 |
Babcák, M | 1 |
Kalanin, P | 1 |
Drazilová, S | 1 |
Babinská, I | 1 |
Cecetková, B | 1 |
Kósa, Z | 1 |
Moravcsik-Kornyicki, Á | 1 |
Diószegi, J | 1 |
Roberts, B | 1 |
Szabó, Z | 1 |
Sándor, J | 1 |
Ádány, R | 1 |
2 other studies available for flumazenil and Dyslipidemia
Article | Year |
---|---|
Prevalence of cardiovascular risk factors in relation to metabolic syndrome in the Roma population compared with the non-Roma population in the eastern part of Slovakia.
Topics: Adolescent; Adult; Age Distribution; Body Mass Index; Cardiovascular Diseases; Comorbidity; Dyslipid | 2014 |
Prevalence of metabolic syndrome among Roma: a comparative health examination survey in Hungary.
Topics: Adult; Comorbidity; Diabetes Mellitus, Type 2; Dyslipidemias; Female; Health Status; Health Surveys; | 2015 |